Evidence map›Paper›PMID 40236602›Full record

ArticlePublic health in practice (Oxford, England)2025

Hepatitis B vaccination coverage and associated factors among children living in northwest Ethiopia city administrations: A community-based study.

Mekuanint Geta, Asrat Hailu, Yimtubezinash Woldeamanuel

Abstract read
In one paragraph

Article in Public health in practice (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mekuanint GetaCenter for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Asrat HailuCenter for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Yimtubezinash WoldeamanuelCenter for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: A study was being conducted to assess the current vaccination coverage, dropout rates, and associated risk factors in children under 15 years old in northwest Ethiopia. Study design: A community-based cross-sectional survey. Methods: A community-based survey was conducted in northwest Ethiopia from January to March 2024. A two-stage cluster-sampling technique was used to select a representative sample. Sociodemographic information, vaccination history, and epidemiological risk factors were collected using a pre-tested, structured questionnaire. Data analysis was performed using SPSS version 23, employing descriptive statistics, chi-square test, and logistic regression model. Associations of vaccination determinants were investigated, with a p-value <0.05 considered statistically significant. Results: In the study, 808 children were surveyed, with 53.0 % being female and 53.0 % were born at hospitals. Most (52.5 %) were under 5 years old, with a mean age of 5.4 ± 3.5 years. Seven hundred thirty four (90.8 %) had received at least one dose of the hepatitis B vaccine, and 82.7 % had received three doses, with a 9.0 % dropout rate. Among children completely vaccinated against hepatitis B, 366 (54.8 %) were in the age group of 1-4 years. The vaccination coverage was 85.4 %, 82.9 %, and 76.5 % in Bahir Dar, Gondar, and Debre Markos, respectively. Several factors have been identified as predictors of complete hepatitis B vaccination in children, including mothers who attended primary school (AOR = 2.9; 95 % CI: 1.4-5.8) and those with secondary education or higher (AOR = 2.2; 95 % CI: 1.3-4.0), married mothers (AOR = 2.5; 95 % CI: 1.5-4.3), and mothers aged 21-30 years (AOR = 2.7; 95 % CI: 1.3-5.6) and those aged 31-40 years (AOR = 2.8; 95 % CI: 1.4-5.5) were more likely to have their children fully vaccinated. Additionally, children born in hospitals (AOR = 2.4; 95 % CI: 1.3-4.3) or health centers (AOR = 4.0; 95 % CI: 2.2-7.4), increased access to vaccination services (AOR = 2.5; 95 % CI: 1.5-4.3), children aged 1-4 years (AOR = 3.1; 95 % CI: 1.7-5.5) and 5-9 years (AOR = 3.8; 95 % CI: 2.1-7.1) had higher HB vaccination coverage. Conclusion: The complete hepatitis B vaccination coverage in this study was lower than the WHO recommendation for developing countries. Therefore, enhancing the promotion of facility delivery and ensuring easy access to vaccines are crucial for improving children's vaccination coverage.

Indexed as

ChildrenCoverageHepatitis B vaccinationNorthwest Ethiopia

Identifiers

PMID40236602
PMCPMC11999313

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.